Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Executive function subdomains are associated with poststroke functional outcome and permanent institutionalization.

Laakso HM, Hietanen M, Melkas S, Sibolt G, Curtze S, Virta M, Ylikoski R, Pohjasvaara T, Kaste M, Erkinjuntti T, Jokinen H.

Eur J Neurol. 2018 Nov 10. doi: 10.1111/ene.13854. [Epub ahead of print]

PMID:
30414288
2.

Costs, outcome and cost-effectiveness of neurocritical care: a multi-center observational study.

Raj R, Bendel S, Reinikainen M, Hoppu S, Laitio R, Ala-Kokko T, Curtze S, Skrifvars MB.

Crit Care. 2018 Sep 20;22(1):225. doi: 10.1186/s13054-018-2151-5.

3.

Cohort profile: Thrombolysis in Ischemic Stroke Patients (TRISP): a multicentre research collaboration.

Scheitz JF, Gensicke H, Zinkstok SM, Curtze S, Arnold M, Hametner C, Pezzini A, Turc G, Zini A, Padjen V, Wegener S, Nordanstig A, Kellert L, Kägi G, Bejot Y, Michel P, Leys D, Nolte CH, Nederkoorn PJ, Engelter ST; TRISP collaboration.

BMJ Open. 2018 Sep 17;8(9):e023265. doi: 10.1136/bmjopen-2018-023265.

4.

Diagnosing cerebral ischemia with door-to-thrombolysis times below 20 minutes.

Pihlasviita S, Mattila OS, Ritvonen J, Sibolt G, Curtze S, Strbian D, Harve H, Pystynen M, Kuisma M, Tatlisumak T, Lindsberg PJ.

Neurology. 2018 Aug 7;91(6):e498-e508. doi: 10.1212/WNL.0000000000005954. Epub 2018 Jul 11.

PMID:
29997196
5.

An Optical Method for the In-Vivo Characterization of the Biomechanical Response of the Right Ventricle.

Soltani A, Lahti J, Järvelä K, Curtze S, Laurikka J, Hokka M, Kuokkala VT.

Sci Rep. 2018 May 1;8(1):6831. doi: 10.1038/s41598-018-25223-z.

6.

Intravenous thrombolysis and platelet count.

Gensicke H, Al Sultan AS, Strbian D, Hametner C, Zinkstok SM, Moulin S, Bill O, Zini A, Padjen V, Kägi G, Pezzini A, Seiffge DJ, Traenka C, Räty S, Amiri H, Zonneveld TP, Lachenmeier R, Polymeris A, Roos YB, Gumbinger C, Jovanovic DR, Curtze S, Sibolt G, Vandelli L, Ringleb PA, Leys D, Cordonnier C, Michel P, Lyrer PA, Peters N, Tatlisumak T, Nederkoorn PJ, Engelter ST; Thrombolysis in Stroke Patients (TRISP) Collaborators.

Neurology. 2018 Feb 20;90(8):e690-e697. doi: 10.1212/WNL.0000000000004982. Epub 2018 Jan 24. Erratum in: Neurology. 2018 Oct 30;91(18):852.

PMID:
29367438
7.

Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors.

Scheitz JF, Turc G, Kujala L, Polymeris AA, Heldner MR, Zonneveld TP, Erdur H, Curtze S, Traenka C, Brenière C, Wiest R, Rocco A, Sibolt G, Gensicke H, Endres M, Martinez-Majander N, Béjot Y, Nederkoorn PJ, Oppenheim C, Arnold M, Engelter ST, Strbian D, Nolte CH; TRISP Collaboration.

Stroke. 2017 Dec;48(12):3239-3244. doi: 10.1161/STROKEAHA.117.018377. Epub 2017 Nov 10.

PMID:
29127269
8.

Non-office-hours admission affects intravenous thrombolysis treatment times and clinical outcome.

Zonneveld TP, Curtze S, Zinkstok SM, Gensicke H, Moulin S, Scheitz JF, Seiffge DJ, Hametner C, Heldner MR, Traenka C, Erdur H, Baharoglu I, Martinez-Majander N, Pezzini A, Zini A, Padjen V, Correia PN, Strbian D, Michel P, Béjot Y, Arnold M, Leys D, Ringleb PA, Tatlisumak T, Nolte CH, Engelter ST, Nederkoorn PJ; TRISP collaborators.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):1005-1007. doi: 10.1136/jnnp-2017-316791. Epub 2017 Oct 25. No abstract available.

PMID:
29070647
9.

Sex Differences and Functional Outcome After Intravenous Thrombolysis.

Spaander FH, Zinkstok SM, Baharoglu IM, Gensicke H, Polymeris A, Traenka C, Hametner C, Ringleb P, Curtze S, Martinez-Majander N, Aarnio K, Nolte CH, Scheitz JF, Leys D, Hochart A, Padjen V, Kägi G, Pezzini A, Michel P, Bill O, Zini A, Engelter ST, Nederkoorn PJ; Thrombolysis in Ischemic Stroke Patients Collaborators (TrISP).

Stroke. 2017 Mar;48(3):699-703. doi: 10.1161/STROKEAHA.116.014739. Epub 2017 Jan 31. Erratum in: Stroke. 2017 Mar;48(3):e97.

PMID:
28143921
10.

Prognostic significance of proteinuria in stroke patients treated with intravenous thrombolysis.

Gensicke H, Frih AA, Strbian D, Zini A, Pezzini A, Padjen V, Haueter M, Seiffge DJ, Mäkitie L, Traenka C, Poli L, Martinez-Majander N, Putaala J, Bonati LH, Sibolt G, Giovannini G, Curtze S, Beslac-Bumbasirevic L, Vandelli L, Lyrer PA, Nederkoorn PJ, Tatlisumak T, Engelter ST; Thrombolysis in Stroke Patients (TRISP) Collaborators.

Eur J Neurol. 2017 Feb;24(2):262-269. doi: 10.1111/ene.13179. Epub 2016 Nov 10.

PMID:
27862667
11.

Cerebral microbleeds in acute ischemic stroke: A red flag for IV thrombolysis.

Raposo N, Curtze S.

Neurology. 2016 Oct 11;87(15):1526-1527. Epub 2016 Sep 14. No abstract available.

PMID:
27629095
12.

Ultra-acute diagnostics for stroke: Large-scale implementation of prehospital biomarker sampling.

Mattila OS, Harve H, Pihlasviita S, Ritvonen J, Sibolt G, Pystynen M, Strbian D, Curtze S, Kuisma M, Tatlisumak T, Lindsberg PJ.

Acta Neurol Scand. 2017 Jul;136(1):17-23. doi: 10.1111/ane.12687. Epub 2016 Sep 18.

PMID:
27642014
13.

Symptomatic post-thrombolytic intracerebral hemorrhage is not related to the cause of stroke.

Curtze S, Sibolt G, Melkas S, Mustanoja S, Haapaniemi E, Putaala J, Sairanen T, Tiainen M, Tatlisumak T, Strbian D.

Eur J Neurol. 2016 Dec;23(12):1700-1704. doi: 10.1111/ene.13128. Epub 2016 Sep 3.

PMID:
27591741
14.

Cerebral white matter lesions and post-thrombolytic remote parenchymal hemorrhage.

Curtze S, Putaala J, Sibolt G, Melkas S, Mustanoja S, Haapaniemi E, Sairanen T, Tiainen M, Tatlisumak T, Strbian D.

Ann Neurol. 2016 Oct;80(4):593-9. doi: 10.1002/ana.24760. Epub 2016 Aug 26.

PMID:
27531598
15.

Repeated Intravenous Thrombolysis for Early Recurrent Stroke: Challenging the Exclusion Criterion.

Kahles T, Mono ML, Heldner MR, Baumgartner RW, Sarikaya H, Luft A, Bohlhalter S, Traenka C, Engelter ST, Kurka N, Köhrmann M, Curtze S, Michel P, Tatlisumak T, Nedeltchev K.

Stroke. 2016 Aug;47(8):2133-5. doi: 10.1161/STROKEAHA.116.013599. Epub 2016 Jun 30.

PMID:
27364530
16.

Step down Vascular Calcification Analysis using State-of-the-Art Nanoanalysis Techniques.

Curtze SC, Kratz M, Steinert M, Vogt S.

Sci Rep. 2016 Mar 16;6:23285. doi: 10.1038/srep23285.

17.

Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke.

Gensicke H, Strbian D, Zinkstok SM, Scheitz JF, Bill O, Hametner C, Moulin S, Zini A, Kägi G, Pezzini A, Padjen V, Béjot Y, Corbiere S, Zonneveld TP, Seiffge DJ, Roos YB, Traenka C, Putaala J, Peters N, Bonati LH, Curtze S, Erdur H, Sibolt G, Koch P, Vandelli L, Ringleb P, Leys D, Cordonnier C, Michel P, Nolte CH, Lyrer PA, Tatlisumak T, Nederkoorn PJ, Engelter ST; Thrombolysis in Stroke Patients (TriSP) Collaborators.

Stroke. 2016 Feb;47(2):450-6. doi: 10.1161/STROKEAHA.115.011674.

PMID:
26797662
18.

Frequency of MELAS main mutation in a phenotype-targeted young ischemic stroke patient population.

Tatlisumak T, Putaala J, Innilä M, Enzinger C, Metso TM, Curtze S, von Sarnowski B, Amaral-Silva A, Jungehulsing GJ, Tanislav C, Thijs V, Rolfs A, Norrving B, Fazekas F, Suomalainen A, Kolodny EH.

J Neurol. 2016 Feb;263(2):257-262. doi: 10.1007/s00415-015-7969-z. Epub 2015 Nov 14.

PMID:
26566914
19.

Severe cerebral white matter lesions in ischemic stroke patients are associated with less time spent at home and early institutionalization.

Sibolt G, Curtze S, Melkas S, Pohjasvaara T, Kaste M, Karhunen PJ, Oksala NK, Erkinjuntti T.

Int J Stroke. 2015 Dec;10(8):1192-6. doi: 10.1111/ijs.12578. Epub 2015 Oct 21.

PMID:
26487377
20.

Undetermined stroke with an embolic pattern--a common phenotype with high early recurrence risk.

Putaala J, Nieminen T, Haapaniemi E, Meretoja A, Rantanen K, Heikkinen N, Kinnunen J, Strbian D, Mustanoja S, Curtze S, Pakarinen S, Lehto M, Tatlisumak T.

Ann Med. 2015;47(5):406-13. doi: 10.3109/07853890.2015.1057612. Epub 2015 Aug 4.

PMID:
26224200
21.

White Matter Lesions Double the Risk of Post-Thrombolytic Intracerebral Hemorrhage.

Curtze S, Haapaniemi E, Melkas S, Mustanoja S, Putaala J, Sairanen T, Sibolt G, Tiainen M, Tatlisumak T, Strbian D.

Stroke. 2015 Aug;46(8):2149-55. doi: 10.1161/STROKEAHA.115.009318. Epub 2015 Jun 25.

PMID:
26111888
22.

Cerebral computed tomography-graded white matter lesions are associated with worse outcome after thrombolysis in patients with stroke.

Curtze S, Melkas S, Sibolt G, Haapaniemi E, Mustanoja S, Putaala J, Sairanen T, Tiainen M, Tatlisumak T, Strbian D.

Stroke. 2015 Jun;46(6):1554-60. doi: 10.1161/STROKEAHA.115.008941. Epub 2015 Apr 21.

PMID:
25899244
23.

Extent of secondary intraventricular hemorrhage is an independent predictor of outcomes in intracerebral hemorrhage: data from the Helsinki ICH Study.

Mustanoja S, Satopää J, Meretoja A, Putaala J, Strbian D, Curtze S, Haapaniemi E, Sairanen T, Niemelä M, Kaste M, Tatlisumak T.

Int J Stroke. 2015 Jun;10(4):576-81. doi: 10.1111/ijs.12437. Epub 2015 Jan 12.

PMID:
25580771
24.

Recognition of posterior circulation stroke.

Puustjärvi V, Strbian D, Tiainen M, Curtze S, Tatlisumak T, Sairanen T.

Acta Neurol Scand. 2015 Jun;131(6):389-93. doi: 10.1111/ane.12351. Epub 2014 Nov 17.

PMID:
25402973
25.

White matter lesions are associated with hospital admissions because of hip-fractures and trauma after ischemic stroke.

Sibolt G, Curtze S, Melkas S, Pohjasvaara T, Kaste M, Karhunen PJ, Oksala NK, Strandberg T, Erkinjuntti T.

Stroke. 2014 Oct;45(10):2948-51. doi: 10.1161/STROKEAHA.114.006116. Epub 2014 Aug 28.

PMID:
25169948
26.

The CAVE score for predicting late seizures after intracerebral hemorrhage.

Haapaniemi E, Strbian D, Rossi C, Putaala J, Sipi T, Mustanoja S, Sairanen T, Curtze S, Satopää J, Roivainen R, Kaste M, Cordonnier C, Tatlisumak T, Meretoja A.

Stroke. 2014 Jul;45(7):1971-6. doi: 10.1161/STROKEAHA.114.004686. Epub 2014 May 29.

PMID:
24876089
27.

Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use.

Curtze S, Strbian D, Meretoja A, Putaala J, Eriksson H, Haapaniemi E, Mustanoja S, Sairanen T, Satopää J, Silvennoinen H, Niemelä M, Kaste M, Tatlisumak T.

Eur J Neurol. 2014 Apr;21(4):616-22. doi: 10.1111/ene.12352. Epub 2014 Jan 21.

PMID:
24447727
28.

Post-stroke depression and depression-executive dysfunction syndrome are associated with recurrence of ischaemic stroke.

Sibolt G, Curtze S, Melkas S, Pohjasvaara T, Kaste M, Karhunen PJ, Oksala NK, Vataja R, Erkinjuntti T.

Cerebrovasc Dis. 2013;36(5-6):336-43. doi: 10.1159/000355145. Epub 2013 Oct 30.

PMID:
24193249
29.

In-hospital cardiac complications after intracerebral hemorrhage.

Putaala J, Lehto M, Meretoja A, Silvennoinen K, Curtze S, Kääriäinen J, Koivunen RJ, Kaste M, Tatlisumak T, Strbian D.

Int J Stroke. 2014 Aug;9(6):741-6. doi: 10.1111/ijs.12180. Epub 2013 Sep 12.

PMID:
24025067
30.

Validation of the DRAGON score in 12 stroke centers in anterior and posterior circulation.

Strbian D, Seiffge DJ, Breuer L, Numminen H, Michel P, Meretoja A, Coote S, Bordet R, Obach V, Weder B, Jung S, Caso V, Curtze S, Ollikainen J, Lyrer PA, Eskandari A, Mattle HP, Chamorro A, Leys D, Bladin C, Davis SM, Köhrmann M, Engelter ST, Tatlisumak T.

Stroke. 2013 Oct;44(10):2718-21. doi: 10.1161/STROKEAHA.113.002033. Epub 2013 Aug 8.

PMID:
23929752
31.

Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage.

Mustanoja S, Strbian D, Putaala J, Meretoja A, Curtze S, Haapaniemi E, Sairanen T, Hietikko R, Sirén J, Kaste M, Tatlisumak T.

Stroke. 2013 Aug;44(8):2330-2. doi: 10.1161/STROKEAHA.113.001829. Epub 2013 Jun 11.

PMID:
23760210
32.

Body temperature, blood infection parameters, and outcome of thrombolysis-treated ischemic stroke patients.

Tiainen M, Meretoja A, Strbian D, Suvanto J, Curtze S, Lindsberg PJ, Soinne L, Tatlisumak T; Helsinki Stroke Thrombolysis Registry Group.

Int J Stroke. 2013 Dec;8(8):632-8. doi: 10.1111/ijs.12039. Epub 2013 Apr 17.

PMID:
23590464
33.

Poststroke dementia is associated with recurrent ischaemic stroke.

Sibolt G, Curtze S, Melkas S, Putaala J, Pohjasvaara T, Kaste M, Karhunen PJ, Oksala NK, Erkinjuntti T.

J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):722-6. doi: 10.1136/jnnp-2012-304084. Epub 2013 Feb 16.

PMID:
23418214
34.

Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients study.

von Sarnowski B, Putaala J, Grittner U, Gaertner B, Schminke U, Curtze S, Huber R, Tanislav C, Lichy C, Demarin V, Basic-Kes V, Ringelstein EB, Neumann-Haefelin T, Enzinger C, Fazekas F, Rothwell PM, Dichgans M, Jungehulsing GJ, Heuschmann PU, Kaps M, Norrving B, Rolfs A, Kessler C, Tatlisumak T; sifap1 Investigators.

Stroke. 2013 Jan;44(1):119-25. doi: 10.1161/STROKEAHA.112.665190. Epub 2012 Nov 13.

PMID:
23150649
35.

SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage.

Meretoja A, Strbian D, Putaala J, Curtze S, Haapaniemi E, Mustanoja S, Sairanen T, Satopää J, Silvennoinen H, Niemelä M, Kaste M, Tatlisumak T.

Stroke. 2012 Oct;43(10):2592-7. Epub 2012 Aug 2.

PMID:
22858729
36.

Carotid embolectomy and endarterectomy for symptomatic complete occlusion of the carotid artery as a rescue therapy in acute ischemic stroke.

Curtze S, Putaala J, Saarela M, Vikatmaa P, Kantonen I, Tatlisumak T.

Case Rep Neurol. 2011 Sep;3(3):301-8. doi: 10.1159/000335069. Epub 2011 Dec 13.

37.

[Diagnosis and treatment of cerebral sinus thrombosis].

Putaala J, Hiltunen S, Curtze S, Salonen O, Tatlisumak T.

Duodecim. 2011;127(16):1656-66. Review. Finnish.

PMID:
21972584
38.

Outcome by stroke etiology in patients receiving thrombolytic treatment: descriptive subtype analysis.

Mustanoja S, Meretoja A, Putaala J, Viitanen V, Curtze S, Atula S, Artto V, Häppölä O, Kaste M; Helsinki Stroke Thrombolysis Registry Group.

Stroke. 2011 Jan;42(1):102-6. doi: 10.1161/STROKEAHA.110.597534. Epub 2010 Nov 24.

PMID:
21106955
39.

Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke.

Putaala J, Sairanen T, Meretoja A, Lindsberg PJ, Tiainen M, Liebkind R, Strbian D, Atula S, Artto V, Rantanen K, Silvonen P, Piironen K, Curtze S, Häppölä O, Mustanoja S, Pitkäniemi J, Salonen O, Silvennoinen H, Soinne L, Kuisma M, Tatlisumak T, Kaste M.

Cerebrovasc Dis. 2011;31(1):83-92. doi: 10.1159/000321332. Epub 2010 Nov 16.

PMID:
21079397
40.

Off-label thrombolysis is not associated with poor outcome in patients with stroke.

Meretoja A, Putaala J, Tatlisumak T, Atula S, Artto V, Curtze S, Häppölä O, Lindsberg PJ, Mustanoja S, Piironen K, Pitkäniemi J, Rantanen K, Sairanen T, Salonen O, Silvennoinen H, Soinne L, Strbian D, Tiainen M, Kaste M.

Stroke. 2010 Jul;41(7):1450-8. doi: 10.1161/STROKEAHA.109.576140. Epub 2010 Jun 10.

PMID:
20538701
41.

Causes of death and predictors of 5-year mortality in young adults after first-ever ischemic stroke: the Helsinki Young Stroke Registry.

Putaala J, Curtze S, Hiltunen S, Tolppanen H, Kaste M, Tatlisumak T.

Stroke. 2009 Aug;40(8):2698-703. doi: 10.1161/STROKEAHA.109.554998. Epub 2009 Jul 9.

PMID:
19590052
42.

Dynamic changes in traction forces with DC electric field in osteoblast-like cells.

Curtze S, Dembo M, Miron M, Jones DB.

J Cell Sci. 2004 Jun 1;117(Pt 13):2721-9. Epub 2004 May 18.

43.

The osteoblast mechano-receptor, microgravity perception and thermodynamics.

Klopp E, Graff D, Struckmeier J, Born M, Curtze S, Hofmann M, Jones D.

J Gravit Physiol. 2002 Jul;9(1):P269-70.

PMID:
15002575

Supplemental Content

Loading ...
Support Center